69 Health Tech Startups in Cambridge to Watch in 2024

Qureight is an imaging analytics company.

Surgical robotic system for minimal access surgery.

Small molecule neoantigen immuno-oncology therapies developer.

Physiological upregulation therapy to treat neurodegenerative diseases.

Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers.

Transforming mental healthcare by unlocking the power of clinical data

Drug delivery platform.

Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.

AI platform to advance precision medicine clinical trials.

Metrion Biosciences is a Contract Research Organization.

Cancer diagnostics.

Endomag is a medical technology company devoted to improving breast cancer care through its magnetic sensing technologies.

Genomics company building safer cell and gene therapies.

AI-driven tech for respiratory conditions.

Supplant is a biotechnology platform that makes sugar substitutes.

Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.

Mogrify® will transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies.

Precision software for surgeries.

Drug manufacturer.

Axol Bioscience sells live human cell cultures and provides services such as genome editing to researchers.

Cake is the world's largest platform for helping people navigate end-of-life.

Eagle Genomics is a enterprise software solutions company to enable the management, orchestration and exploitation of life sciences data.

Epitopea is a transatlantic cancer immunotherapeutics company.

Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology.

Deubiquitylating enzyme (DUB) drug discovery and development platform.

PetMedix is a pet therapeutics startup.

PillSorted is a Pharmacy, blending compassionate care and innovative technology to deliver a truly Personal Pharmacy service.

Owlstone Medical is a diagnostics company that developed a non-invasive breathalyzer for infectious disease detection.

Cambridge Epigenetix is using epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw.

Artios Pharma is a independent DNA Damage Response company with a strong pipeline of novel cancer therapies.

Sphere Fluidics develops products for use in single cell analysis and characterization, and provides associated collaborative R&D services.

Semarion leverages microfabrication technology to build smart materials and develop novel cell assaying applications.

Novel cancer therapies.

PhoreMost is a new-model drug discovery company based in Cambridge, UK.

Wren Therapeutics is a biopharmaceutical company based, focused on drug discovery and development for protein misfolding diseases.

Transforming the way a nation delivers its healthcare to its population, from prescriptions to personalised services.

Clinical stage studies to discover biomarkers to improve medical diagnosis.

Charco Neurotech is a medical technology company that develops non-invasive wearable devices.

CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery.

NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore mitochondrial function.

Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance.

Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.

PsyOmics develops proteomic diagnostics to improve early diagnosis and treatment outcomes for those with neuropsychiatric disorders.

Treatment for patients with chronic wounds.

Spotta is a provider of smart pest systems.

Genomic technology developer to detect biomarkers for non-small cell lung cancer (NSCLC).

Transine Therapeutics is a developer of a platform for physiological upregulation of proteins using targeted translation enhancers, SINEUPs.

Monocl empowers life science professionals with the complete global expert solution for impactful outreach and strategic engagement.

Spirea Ltd. operates as a healthcare technology company.

PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery.

Congenica is a biotechnology company that provides a diagnostic decision support platform.

AI extracting health data from sound.

52 North Health is developing a fully-integrated clinical, AI-driven medical device-based system called NeutroCheck for people with cancer.

Legacy is a digital fertility clinic for men, founded at Harvard & backed by Y Combinator, FirstMark Capital, Bain Capital and celebrities.

PolyProx Therapeutics is a developer of a novel class of drug intended to provide new therapies for cancer treatment.

Definigen provides human cells to the drug discovery sector for use in lead optimization and toxicity programs.

Z Factor Limited is a drug discovery company to identify and develop therapeutic agents to treat alpha-1-antitrypsin deficiency

Kirontech uses cutting edge machine learning technology to revolutionize the use of healthcare data.

Revolo Biotherapeutics has developed therapies that achieve superior long-term disease remission from less frequent chronic dosing.

Cambridge Cancer Genomics develops precision oncology solutions to transform the way cancer patients are treated.

CS Genetics develops new technology for genomics, based on scientific insights and conceptual innovations in NGS techniques.

Produce pure, mature and highly consistent batches of human cell types for research, toxicology and drug development.

Horizon is a gene editing company that designs & engineers genetically-modified cells, applying them to advance human health.

Crescendo Biologics is engaged in the development of a proprietary drug portfolio based on their VH antibody fragment platform.

MORPHOGEN-IX Limited is a drug discovery company founded in 2015 by Index Ventures to develop bone morphogenetic proteins

Mursla is a quantum biology diagnostics company.

Nemesis Bioscience is a new biopharmaceutical company .

Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.

Exonate is a biotech company spun out of the University of Nottingham that is focused on alternative splicing of (VEGF) in ophthalmology.